Christine Poitou

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 162 publications

Eating behaviour phenotype in the MYT1L-related neurodevelopmental disorder: a deep phenotyping study using standardized questionnaires.

Eating behaviour phenotype in the MYT1L-related neurodevelopmental disorder: a deep phenotyping study using standardized questionnaires.

Journal: Orphanet journal of rare diseases

Published: July 21, 2026

Defining Acquired Hypothalamic Obesity: An Expert Call for Unified Diagnosis and Therapeutic Action.

Defining Acquired Hypothalamic Obesity: An Expert Call for Unified Diagnosis and Therapeutic Action.

Journal: Diabetes, obesity & metabolism

Published: January 21, 2026

SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.

SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.

Journal: Diabetes, obesity & metabolism

Published: January 06, 2026

Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes.

Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes.

Journal: Gut microbes

Published: December 18, 2025

Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders.

Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 08, 2025

Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders.

Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 08, 2025

Efficacy and Safety of Bariatric Surgery in Acquired Hypothalamic Obesity: A Systematic Review and Individual Patient Data Meta-Analysis.

Efficacy and Safety of Bariatric Surgery in Acquired Hypothalamic Obesity: A Systematic Review and Individual Patient Data Meta-Analysis.

Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity

Published: September 30, 2025

Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks.

Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks.

Journal: Diabetes & metabolism

Published: July 18, 2025

Effectiveness and safety of GLP-1 receptor agonists in craniopharyngioma patients with obesity: A multicentre real-world study.

Effectiveness and safety of GLP-1 receptor agonists in craniopharyngioma patients with obesity: A multicentre real-world study.

Journal: Diabetes, obesity & metabolism

Published: June 30, 2025

Characterization of jejunal enteroids in human obesity; a model for studying GLP-1 cells.

Characterization of jejunal enteroids in human obesity; a model for studying GLP-1 cells.

Journal: International journal of obesity (2005)

Published: May 15, 2025

Early-Onset of Obesity Model: Impact of Early-Onset Obesity on Comorbidity Risk and Life Expectancy.

Early-Onset of Obesity Model: Impact of Early-Onset Obesity on Comorbidity Risk and Life Expectancy.

Journal: Obesity facts

Published: May 08, 2025

Effectiveness of topiramate in the treatment of behavioural disorders in Prader-Willi syndrome.

Effectiveness of topiramate in the treatment of behavioural disorders in Prader-Willi syndrome.

Journal: Journal of psychiatry & neuroscience : JPN

Published: April 23, 2025

Showing 1-12 of 162

Last Updated: 09/26/2026